Green tea (Camellia sinensis)
What is it?
Scientific names
Green tea is derived from Camellia sinensis, an evergreen shrub of the Theaceae family, which grows mainly in parts of Asia, the Middle East and Africa. It comes from the same plant as black tea but it is produced in a non-fermenting process thus is believed to be the strongest tea with the least loss of herbal elements. According to the fermentation degree and plants sources, there are classifications as green tea, white tea, yellow tea, black tea and dark tea. With increasing fermentation, the number of bioactive elements decreases.
Ingredients
The main active ingredients identified in green tea include polyphenolic compounds such as epicatechin (EC), epicatechin-3-gallate (ECG), epigallocatechin (EGC), and epigallocatechin-3-gallate (EGCG), which are thought to be responsible for their anti-carcinogenic and anti-mutagenic activity. Other polyphenols in green tea include flavanols and their glycosides and depsides such as cholorogenic acid, quinic acids, carotenoids, trigalloylglucose, lignin, protein, chlorophyll, minerals (depending on the soil content, aluminum and manganese), caffeine, and very small amount of methylxanthines.
Application and dosage
Green tea can be consumed as a brewed beverage or as dietary supplements in form of liquids, capsules, or tablets containing green tea extract. Commercial products, or green tea for medicinal use, are provided by tea manufacturers or different pharmaceutical herbal medicine companies. Water for green tea should be around 80 to 85 °C; the higher the quality of the leaves, the lower the temperature; high-quality green teas can have new water added as many as five times. Currently, there is no established recommended dose for green tea extract. For cancer prevention, studies have examined the effects of habitually drinking between one to ten cups per day, although these findings require confirmation.
History/providers
Green tea consumption began in China with legendary origins of more than 4,000 years ago. A legend suggests it was an Emperor called Shen Nung who accidentally discovered tea. Then green tea has an origin linked to the highest tier of Chinese society, which made it expensive and only accessible to the rich. It was not until the 14th century that green tea become widespread throughout China. It has been used for its taste and medicinal qualities in most of Asia. In the 16th century, green tea was introduced to European and the USA 1.
The Kissa Yojoki (Book of Tea), written by Zen priest Eisai in 1191, describes how drinking green tea can have a positive effect on the five vital organs and discusses tea's medicinal qualities 2.
Claims of efficacy/alleged indications
Green tea contains antioxidants and research reports a variety of green tea’s health benefits are reported including cancer prevention, reduced risk for cardiovascular disease, increased bone density, fat loss promotion and protection against neurodegenerative disease.
Mechanism of action
Human studies on the pharmacokinetics of green tea polyphenols have been conducted. Polyphenols from green tea have been shown to be powerful antioxidants with anticarcinogenic properties. EGCG, the most abundant and biologically active polyphenol in green tea, induces apoptosis and suppresses proliferation of cancer cells by modulating multiple signal transduction pathways. EGCG can also covalently bind to cysteine residues in proteins through autoxidation and subsequently modulate protein function 3. Studies have shown that tea catechins inhibit hepatocyte growth factor receptor (MET kinase) activity in human colon cancer cells.
Prevalence of use
Tea is the most popular beverage next to water around the world, and green tea accounts for 20% of tea consumption. It is particularly popular in China, Japan, and other South-East Asian countries.
Legal issues
Green tea is sold as beverage or dietary supplement. It therefore does not need to be approved by the FDA or EMA (European Medicines Agency), but no medicinal claims associated with green tea can be made.
Cost and expenditure
The cost of green tea differs substantially due to variable growing conditions, horticulture, production processing and harvesting time. Therefore, on the Internet in China, prices for green tea generally range from RMB 22.00yuan/500g to RMB 2350.00 yuan/500g in bulk. Green tea if well packed will be expensive. The price of green tea in the USA and Europe is about 17 USD per 500 mg 100 caps.
Citation
Jianping Liu, Xun Li , CAM-Cancer Consortium. Green tea (Camellia sinensis) [online document]. http://www.cam-cancer.org/CAM-Summaries/Herbal-products/Green-tea-Camellia-sinensis. May 8, 2012.Document history
Summary last updated and revised in May 2012 by Jianping Liu and Xun Li.
Summary fully updated and revised in April 2012 by Jianping Liu and Xun Li.
Summary first published in September 2005, authored by Jianping Liu.
References
- History of green tea. http://www.greenteas.com/history-of-green-tea.php (acessed 08.05.12)
- Green tea. Retrieved Feb. 25, 2012, from http://en.wikipedia.org/wiki/Green tea (acessed 08.05.12)
- Tanaka T, Ishii T, Mizuno D, ect. (-)-Epigallocatechin-3-gallate suppresses growth of AZ521 human gastric cancer cells by targeting the DEAD-box RNA helicase p68. Free Radical Biology and Medicine 2011, 50(10):1324-1335.
- Yuan JM, Sun C, Butler LM. Tea and cancer prevention: epidemiological studies. Pharmarcology research 2011, 64(2):123-135.
- Liu J, Xing J, Fei Y. Green tea (Camellia sinensis) and cancer prevention: a systematic review of randomized trials and epidemiological studies. Chin Med. 2008 Oct 22;3:12.
- Boehm K, Borrelli F, Ernst E, Habacher G, Hung SK, Milazzo S, Horneber M. Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD005004. DOI: 10.1002/14651858.CD005004.pub2.
- Butler LM, Wu AH. Green and black tea in relation to gynecologic cancers. Molecular Nutrition & Food Research 2011; 55(6):931-940.
- Nagle CM, Olsen CM, Bain CJ, etc. Tea consumption and risk of ovarian cancer. Cancer Causes and Control 2010; 21(9):1485-1491.
- Zheng J, Yang B, Huang T, Yu Y, Yang J, Li D. Green tea and black tea consumption and prostate cancer risk: an exploratory meta-analysis of observational studies. Nutrition and Cancer 2011; 63(5):663-672.
- Sing MF, Yang WS, Gao S, ect. Epidemiological studies of the association between tea drinking and primary liver cancer: a meta-analysis. European Journal of Cancer Prevention. 2011, 20(3):157-165.
- Kang H., Rha SY, Oh KW, Nam CM. Green tea consumption and stomach cancer risk: a meta-analysis. Epidemiology and Health 2010; 32:e2010001.
- Myung SK, Bae WK, Oh SM, Kim Y, Ju W, Sung J, Lee YJ, Ko JA, Song JI, Choi HJ. Green tea consumption and risk of stomach cancer: a meta-analysis of epidemiologic studies. Int J Cancer 2009; 124:670-7.
- Sun CL, Yuan JM, Koh WP, Yu MC. Green tea, black tea and colorectal cancer risk: a meta-analysis of epidemiologic studies. Carcinogenesis 2006; 27:1301-9.
- Ogunleye AA, Xue F, Michels KB. Green tea consumption and breast cancer risk or recurrence: a meta-analysis. Breast Cancer Res Treat. 2010; 119:477-484.
- Tang N, Wu Y, Zhou B, Wang B, Yu R. Green tea, black tea consumption and risk of lung cancer: a meta-analysis. Lung Cancer. 2009; 65: 274-83.
- Anonymous. Green tea detailed scientific review. The University of Texas MD Anderson Cancer Center. http://www.mdanderson.org/education-and-research/resources-for-professionals/clinical-tools-and-resources/cimer/index.html (acessed 08.05.12)
- Brown MD. Green tea (Camellia sinensis) extract and its possible role in the prevention of cancer. Altern Med Rev 1999;4:360-70.
- The Natural Medicines Comprehensive Database. http://www.naturaldatabase.com/ (acessed 08.05.12)
- Thomas F, Holly JM, Persad R, ect. Green tea extract (epigallocatechin-3-gallate) reduces efficacy of radiotherapy on prostate cancer cells. Urology 2011; 78(2):421-475.
- Qiao J, Gu C, Shang W, ect. Effect of green tea on pharmacokinetics of 5-fluorouracil in rats and pharmacodynamics in human cell lines in vitro. Food and Chemical Toxicology 2011; 49(6):1410-1415.
- Sarma DN, Barrett ML, Chavez ML, Gardiner P, Ko R, Mahady GB, Marles RJ, Pellicore LS, Giancaspro GI, Low Dog T. Safety of green tea extracts: a systematic review by the US Pharmacopeia. Drug Saf. 2008;31(6):469-84.
- Bannerman B, Xu L, Jones M et al. Preclinical evaluation of the antitumor activity of bortezomib in combination with vitamin C or with epigallocatechin gallate, a component of green tea. Cancer Chemother Pharmacol. 2011;68(5):1145-54.
- Golden EB, Lam PY, Kardosh A et al. Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors.Blood. 2009;113(23):5927-37.
The present documentation has been compiled by the CAM-CANCER Project with all due care and expert knowledge. However, the CAM-CANCER Project provides no assurance, guarantee or promise with regard to the correctness, accuracy, up-to-date status or completeness of the information it contains. This information is designed for health professionals. Readers are strongly advised to discuss the information with their physician. Accordingly, the CAM-CANCER Project shall not be liable for damage or loss caused because anyone relies on the information.



